Kriti Nutrients Limited carries a market capitalization of 4.18B, placing it among publicly traded companies globally. Its enterprise value stands at 2.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.18B |
| Enterprise Value | 2.18B |
Kriti Nutrients Limited currently has 50.10M shares outstanding.
| Shares Outstanding | 50.10M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Kriti Nutrients Limited trades at a trailing price-to-earnings ratio of 8.00. The price-to-sales ratio is 0.29, and the price-to-book ratio stands at 54.11.
| PE Ratio | 8.00 |
| PS Ratio | 0.29 |
| PB Ratio | 54.11 |
| P/TBV Ratio | 1.18 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Kriti Nutrients Limited trades at an EV/EBITDA multiple of 5.78 and an EV/FCF ratio of 530.57. The EV/Sales ratio of 0.24 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5.78 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.24 |
| EV / EBITDA | 5.78 |
| EV / EBIT | 5.78 |
| EV / FCF | 530.57 |
Kriti Nutrients Limited maintains a current ratio of 3.70, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.97, indicating elevated leverage, while an interest coverage ratio of 68.81 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.70 |
| Quick Ratio | 1.68 |
| Debt / Equity | 3.97 |
| Debt / EBITDA | 0.24 |
| Interest Coverage | 68.81 |
Kriti Nutrients Limited posts a return on equity of 35.96 and a return on invested capital of 12.46.
| Return on Equity (ROE) | 35.96 |
| Return on Assets (ROA) | 13.28 |
| Return on Invested Capital (ROIC) | 12.46 |
| Return on Capital Employed (ROCE) | 34.19 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 18.81 |
Over the trailing twelve months, Kriti Nutrients Limited has paid 112.70M in income taxes, reflecting an effective tax rate of 24.98.
| Income Tax | 112.70M |
| Effective Tax Rate | 24.98 |
Kriti Nutrients Limited's stock has declined approximately -30.09337% over the past 52 weeks. The 50-day moving average sits at 89.03, while the 200-day moving average is 79.83.
| Beta (5Y) | N/A |
| 52-Week Price Change | -30.09337% |
| 50-Day Moving Average | 89.03 |
| 200-Day Moving Average | 79.83 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Kriti Nutrients Limited generated 9.22B in revenue and converted that into 339.01M in net income, yielding earnings per share of 6.75. EBITDA reached 376.89M, while operating income came in at 376.89M.
| Revenue | 9.22B |
| Gross Profit | 1.00B |
| Operating Income | 376.89M |
| Pretax Income | 451.10M |
| Net Income | 339.01M |
| EBITDA | 376.89M |
| EBIT | 376.89M |
| Earnings Per Share (EPS) | 6.75 |
Kriti Nutrients Limited holds 622.12M in cash and equivalents against 91.01M in total debt, resulting in a net debt position of -386.95M. Total book value stands at 50.10M, with working capital of 1.00B providing operational flexibility.
| Cash & Cash Equivalents | 622.12M |
| Total Debt | 91.01M |
| Net Debt | -386.95M |
| Equity (Book Value) | 50.10M |
| Book Value Per Share | 1.00 |
| Working Capital | 1.00B |
Kriti Nutrients Limited operates with a gross margin of 10.88, reflecting its pricing power and cost economics. The operating margin of 4.09 and net profit margin of 3.68 provide insight into operational efficiency.
| Gross Margin | 10.88 |
| Operating Margin | 4.09 |
| Pretax Margin | 4.90 |
| Profit Margin | 3.68 |
| EBITDA Margin | 4.09 |
Kriti Nutrients Limited posts an Altman Z-Score of 8.01, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.01 |